EMA News
🇪🇺 EMA Page 3EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Get critical EMA regulatory updates for drug approvals, clinical trials, and market access in Europe & UK. Stay ahead of pharma compliance.
Showing 25–36 of 69 articles
Navigating the Future of GMP: Reliance, Annex 1, and AI
EMA Initiates Implementation of New EU Pharmaceutical Legislation: What Pharma Needs to Know
Regeneron Pharma Stock Holds Steady Amid EMA Eye Drug Review and Analyst Target Adjustment
Teva's Once-Monthly Schizophrenia Shot Enters EMA Review, Signaling New Treatment Option
Ascentage Pharma's Olverembatinib Update: Insights from ASCO 2026
Ascentage Pharma's 17 Clinical Advances at EHA 2026
EMA Endorses Novo Nordisk's Wegovy for Weight Loss
EU Panel Endorses Expanded Applications for Cancer Medications
EMA Management Board Meeting Highlights: March 2026 on Clinical Trials
EMA's CHMP Endorses Four New Medicines: May Meeting Insights
EU Draft Deal Addresses Essential Medicine Shortages
CHMP Meeting Highlights: Drug Approvals from May 2026